www.diseases-diagnosis.com Homepage Diseases Symptoms Diseases Diagnosis Diseases Treatment Diseases Living Care Diseases Prevention Diseases Research
www
Search
Friday, September 22nd, 2017
Table of Contents

1 Introduction
5 PMID
 [F] Diseases Research  / PubMed Research Articles  /
Burden of chronic urticaria relative to psoriasis in five European countries.

PubMed

 

Resource

Journal of the European Academy of Dermatology and Venereology : JEADV 2017 Sep 12; ()

Authors

Balp MM1; Khalil S2; Tian H3; Gabriel S4; Vietri J5; Zuberbier T6;

Author Information
  • 1Novartis Pharma AG, Basel, Switzerland.
  • 2Novartis Pharma AG, Basel, Switzerland.
  • 3Novartis Pharmaceutical Corporation, East Hanover, NJ, USA.
  • 4Novartis Pharmaceutical Corporation, East Hanover, NJ, USA.
  • 5Kantar Health, Horsham, PA, USA.
  • 6Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Abstract

BACKGROUND: Quantification of burden of chronic spontaneous urticaria (CSU) versus psoriasis (PsO) is limited.

OBJECTIVE: To evaluate the burden associated with CSU versus PsO of all severities (overall PsO), mild and moderate/severe PsO.

METHODS: his retrospective cross-sectional analysis compared data from adult patients with chronic urticaria (CU), used as a proxy for CSU, and PsO from the National Health and Wellness Survey in France, Germany, Italy, Spain, and the United Kingdom. Outcomes included mental and physical component summary scores (MCS and PCS) calculated from the Short-Form (SF)-36v2 or SF-12v2, SF-6D health utility scores, self-reported psychological complaints (anxiety, depression, and sleep difficulties), work productivity and activity impairment, and self-reported health care resource utilisation. Bivariate and multivariate analyses for each outcome and comparative group were conducted.

RESULTS: This analysis included 769 CU and 7857 PsO (26.9% moderate/severe) patients. Following adjustment for covariates, CU patients showed a greater health-related quality of life (HRQoL) impairment versus overall PsO (MCS:-2.4, PCS:-1.6, SF-6D:-0.03; all p< 0.001). CU patients showed a higher risk of anxiety, depression, and sleep difficulties (odds ratio [OR]: 1.63, 1.34, and 1.56, respectively; all P< 0.01) and greater healthcare resource use versus overall PsO. The overall activity impairment was significantly greater in CU patients than in overall PsO patients (P=0.001) while the impact on work was not-significantly different. The results vs. moderate/severe PsO group showed no significant differences on all outcomes.

CONCLUSION: Burden of illness in CU is higher than PsO of all severities but similar to that observed in moderate/severe PsO. Both diseases have a similar negative impact on work productivity. This article is protected by copyright. All rights reserved.

This article is protected by copyright. All rights reserved.

PMID

28898460

Others

Publication Type: Journal Article


This article is licensed under the the National Library of Medicine License. It uses material from the PubMed National Library of Medicine Data.


Last Modified:   2016-03-27


Search
All informatin on the site is © www.diseases-diagnosis.com 2002-2016. Last revised: March 27, 2016
Are you interested in our site or/and want to use our information? please read how to contact us and our copyrights.
To let us provide you with high quality information, you can help us by making a more or less donation: